ICM
NVIV
IMS Capital Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-20,146
| Closed | -$7K | – | 156 |
|
2022
Q1 | $7K | Hold |
20,146
| – | – | ﹤0.01% | 140 |
|
2021
Q4 | $9K | Hold |
20,146
| – | – | ﹤0.01% | 137 |
|
2021
Q3 | $14K | Buy |
20,146
+9,997
| +99% | +$6.95K | 0.01% | 134 |
|
2021
Q2 | $8K | Sell |
10,149
-3
| -0% | -$2 | ﹤0.01% | 130 |
|
2021
Q1 | $10K | Buy |
+10,152
| New | +$10K | 0.01% | 123 |
|
2020
Q1 | – | Sell |
-23,472
| Closed | -$5K | – | 147 |
|
2019
Q4 | $5K | Buy |
+23,472
| New | +$5K | ﹤0.01% | 132 |
|
2019
Q3 | – | Sell |
-29,291
| Closed | -$22K | – | 139 |
|
2019
Q2 | $22K | Hold |
29,291
| – | – | 0.02% | 123 |
|
2019
Q1 | $45K | Sell |
29,291
-245
| -0.8% | -$376 | 0.04% | 115 |
|
2018
Q4 | $35K | Sell |
29,536
-2,218
| -7% | -$2.63K | 0.03% | 117 |
|
2018
Q3 | $64K | Buy |
31,754
+6,838
| +27% | +$13.8K | 0.04% | 180 |
|
2018
Q2 | $42K | Sell |
24,916
-599,757
| -96% | -$1.01M | 0.03% | 167 |
|
2018
Q1 | $481K | Hold |
624,673
| – | – | 0.3% | 84 |
|
2017
Q4 | $481K | Buy |
624,673
+128,864
| +26% | +$99.2K | 0.3% | 84 |
|
2017
Q3 | $731K | Buy |
495,809
+104,660
| +27% | +$154K | 0.47% | 67 |
|
2017
Q2 | $1.06M | Sell |
391,149
-44,839
| -10% | -$121K | 1% | 31 |
|
2017
Q1 | $1.77M | Buy |
435,988
+9,050
| +2% | +$36.7K | 1.77% | 8 |
|
2016
Q4 | $1.79M | Buy |
426,938
+325
| +0.1% | +$1.37K | 1.92% | 6 |
|
2016
Q3 | $2.9M | Buy |
426,613
+102,465
| +32% | +$697K | 3.34% | 3 |
|
2016
Q2 | $1.87M | Buy |
324,148
+53,649
| +20% | +$310K | 2.19% | 5 |
|
2016
Q1 | $1.89M | Buy |
270,499
+23,533
| +10% | +$164K | 2.29% | 7 |
|
2015
Q4 | $1.78M | Buy |
246,966
+13,727
| +6% | +$98.8K | 2.19% | 6 |
|
2015
Q3 | $2.01M | Buy |
233,239
+65,646
| +39% | +$566K | 2.41% | 4 |
|
2015
Q2 | $2.71M | Buy |
+167,593
| New | +$2.71M | 3.22% | 2 |
|